Pharmagreen Biotech Value At Risk
| PHBI Stock | | | USD 0.0018 0.0002 12.50% |
The Value At Risk indicator for Pharmagreen Biotech is derived from observed market data. The calculation draws on time-series market data across available periods. Exchange-specific data schedules may affect the recency of readings. Pharmagreen Biotech has a market cap of 2.96 M. Review
Your Equity Center for a broader allocation view. Current allocation data is available for review. Allocation context is based on the most recent position data. All values are presented as reference data. This reflects a position in Pharmagreen Biotech. This is situated within the portfolio mix. The allocation framework shapes how individual positions are weighted. The dataset is presented as structured reference material for independent review. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
Pharmagreen Biotech has current Value At Risk of
-14.29. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -14.29 | |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Pharmagreen Biotech is rated
below average for value at risk among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Pharmagreen Biotech to Peers
Other Technical Indicators